| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Thiamine | 5 | 2019 | 21 | 1.420 |
Why?
|
| Pulmonary Embolism | 11 | 2012 | 176 | 1.300 |
Why?
|
| Emergency Service, Hospital | 32 | 2024 | 1118 | 1.290 |
Why?
|
| Heart Failure | 5 | 2019 | 926 | 1.000 |
Why?
|
| Emergency Medicine | 7 | 2014 | 193 | 0.750 |
Why?
|
| Phosphocreatine | 2 | 2011 | 25 | 0.700 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 6 | 2012 | 13 | 0.650 |
Why?
|
| Male | 71 | 2025 | 30323 | 0.650 |
Why?
|
| Cardiovascular Agents | 1 | 2019 | 104 | 0.560 |
Why?
|
| Dyspnea | 3 | 2019 | 124 | 0.550 |
Why?
|
| Spermatic Cord Torsion | 2 | 2008 | 13 | 0.540 |
Why?
|
| Female | 66 | 2025 | 33382 | 0.530 |
Why?
|
| Middle Aged | 51 | 2025 | 17923 | 0.530 |
Why?
|
| Humans | 87 | 2025 | 64279 | 0.490 |
Why?
|
| Prospective Studies | 31 | 2015 | 3318 | 0.480 |
Why?
|
| Emergency Treatment | 5 | 2008 | 58 | 0.470 |
Why?
|
| Research | 3 | 2005 | 196 | 0.470 |
Why?
|
| Pelvis | 2 | 2006 | 61 | 0.450 |
Why?
|
| Myocardial Ischemia | 2 | 2007 | 117 | 0.440 |
Why?
|
| Health Personnel | 3 | 2025 | 389 | 0.440 |
Why?
|
| Heart Arrest | 10 | 2016 | 177 | 0.430 |
Why?
|
| Aged | 37 | 2025 | 14664 | 0.420 |
Why?
|
| Tomography, X-Ray Computed | 6 | 2015 | 1669 | 0.410 |
Why?
|
| Abdomen, Acute | 2 | 2006 | 23 | 0.400 |
Why?
|
| Acid-Base Imbalance | 1 | 2013 | 4 | 0.400 |
Why?
|
| Bacterial Infections | 2 | 2025 | 153 | 0.400 |
Why?
|
| Bicarbonates | 1 | 2013 | 17 | 0.400 |
Why?
|
| Pyloric Stenosis, Hypertrophic | 1 | 2013 | 8 | 0.400 |
Why?
|
| Electrolytes | 1 | 2013 | 25 | 0.400 |
Why?
|
| Water-Electrolyte Imbalance | 1 | 2013 | 10 | 0.400 |
Why?
|
| Contrast Media | 3 | 2006 | 429 | 0.390 |
Why?
|
| Chlorides | 1 | 2013 | 31 | 0.390 |
Why?
|
| Potassium | 1 | 2013 | 100 | 0.390 |
Why?
|
| Abdominal Pain | 3 | 2017 | 101 | 0.380 |
Why?
|
| Unnecessary Procedures | 2 | 2012 | 49 | 0.380 |
Why?
|
| Posture | 2 | 2007 | 126 | 0.380 |
Why?
|
| Vomiting | 1 | 2013 | 138 | 0.370 |
Why?
|
| Muscle, Skeletal | 3 | 2011 | 747 | 0.360 |
Why?
|
| Pulmonary Artery | 1 | 2012 | 97 | 0.350 |
Why?
|
| Acute Disease | 7 | 2019 | 672 | 0.350 |
Why?
|
| Emergency Medical Services | 3 | 2010 | 267 | 0.340 |
Why?
|
| Physical Endurance | 1 | 2011 | 48 | 0.340 |
Why?
|
| Sepsis | 2 | 2025 | 290 | 0.340 |
Why?
|
| Diagnostic Errors | 1 | 2012 | 104 | 0.340 |
Why?
|
| Oxygen | 5 | 2010 | 321 | 0.340 |
Why?
|
| Dyspnea, Paroxysmal | 1 | 2010 | 2 | 0.340 |
Why?
|
| Weights and Measures | 1 | 2010 | 2 | 0.340 |
Why?
|
| Phosphates | 1 | 2011 | 93 | 0.330 |
Why?
|
| Time Factors | 13 | 2020 | 3726 | 0.330 |
Why?
|
| Adult | 35 | 2025 | 17133 | 0.320 |
Why?
|
| Electrocardiography | 4 | 2009 | 554 | 0.320 |
Why?
|
| Muscle Contraction | 1 | 2011 | 202 | 0.310 |
Why?
|
| Venous Thromboembolism | 3 | 2010 | 147 | 0.310 |
Why?
|
| Pneumonia | 2 | 2012 | 291 | 0.310 |
Why?
|
| Physicians | 3 | 2010 | 483 | 0.310 |
Why?
|
| Radiography, Abdominal | 2 | 2006 | 26 | 0.300 |
Why?
|
| Double-Blind Method | 11 | 2016 | 744 | 0.300 |
Why?
|
| Oximetry | 1 | 2009 | 48 | 0.300 |
Why?
|
| Aged, 80 and over | 13 | 2025 | 5528 | 0.290 |
Why?
|
| Thermography | 1 | 2008 | 7 | 0.290 |
Why?
|
| Hypoxia | 1 | 2009 | 116 | 0.280 |
Why?
|
| Severity of Illness Index | 9 | 2025 | 1561 | 0.280 |
Why?
|
| Informed Consent | 2 | 1999 | 141 | 0.270 |
Why?
|
| Sodium Potassium Chloride Symporter Inhibitors | 1 | 2007 | 12 | 0.270 |
Why?
|
| Furosemide | 1 | 2007 | 20 | 0.270 |
Why?
|
| Tomography, Spiral Computed | 2 | 2010 | 22 | 0.270 |
Why?
|
| Cardiopulmonary Resuscitation | 6 | 2016 | 94 | 0.260 |
Why?
|
| Terrorism | 2 | 2004 | 16 | 0.260 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 210 | 0.260 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 223 | 0.260 |
Why?
|
| Vitamin B Complex | 1 | 2007 | 15 | 0.260 |
Why?
|
| Logistic Models | 8 | 2013 | 1270 | 0.260 |
Why?
|
| Reproducibility of Results | 8 | 2011 | 1683 | 0.250 |
Why?
|
| Asthma | 4 | 2014 | 471 | 0.250 |
Why?
|
| Iothalamate Meglumine | 1 | 2006 | 2 | 0.250 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2006 | 44 | 0.250 |
Why?
|
| Presenteeism | 1 | 2025 | 5 | 0.240 |
Why?
|
| Hydrocortisone | 4 | 2016 | 193 | 0.240 |
Why?
|
| Oxygen Consumption | 3 | 2003 | 212 | 0.230 |
Why?
|
| Hospitalization | 5 | 2019 | 1368 | 0.220 |
Why?
|
| Observer Variation | 4 | 2010 | 215 | 0.220 |
Why?
|
| Hospital Communication Systems | 1 | 2004 | 3 | 0.220 |
Why?
|
| Ketorolac Tromethamine | 1 | 2004 | 5 | 0.220 |
Why?
|
| Surveys and Questionnaires | 3 | 2010 | 2738 | 0.220 |
Why?
|
| Noise, Occupational | 1 | 2004 | 14 | 0.210 |
Why?
|
| Blast Injuries | 1 | 2004 | 5 | 0.210 |
Why?
|
| Explosions | 1 | 2004 | 6 | 0.210 |
Why?
|
| Myocardial Infarction | 2 | 2002 | 915 | 0.210 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2004 | 36 | 0.210 |
Why?
|
| Cell Phone | 1 | 2004 | 43 | 0.210 |
Why?
|
| Atrial Natriuretic Factor | 1 | 2003 | 6 | 0.210 |
Why?
|
| Pain Measurement | 4 | 2010 | 349 | 0.200 |
Why?
|
| United States | 14 | 2021 | 7923 | 0.200 |
Why?
|
| Intuition | 1 | 2003 | 2 | 0.200 |
Why?
|
| Venous Thrombosis | 2 | 2010 | 113 | 0.200 |
Why?
|
| Creatine Kinase | 1 | 2003 | 42 | 0.200 |
Why?
|
| Delivery of Health Care | 3 | 2023 | 437 | 0.200 |
Why?
|
| Troponin I | 1 | 2003 | 35 | 0.200 |
Why?
|
| Carbon Monoxide Poisoning | 1 | 2003 | 13 | 0.190 |
Why?
|
| Isoenzymes | 1 | 2003 | 141 | 0.190 |
Why?
|
| Teaching Materials | 1 | 2002 | 12 | 0.190 |
Why?
|
| Predictive Value of Tests | 7 | 2015 | 1105 | 0.190 |
Why?
|
| Videotape Recording | 1 | 2002 | 46 | 0.190 |
Why?
|
| Practice Patterns, Physicians' | 2 | 2016 | 708 | 0.190 |
Why?
|
| Administration, Oral | 3 | 2012 | 374 | 0.190 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2014 | 771 | 0.190 |
Why?
|
| Artificial Intelligence | 1 | 2025 | 197 | 0.190 |
Why?
|
| Thiamine Deficiency | 2 | 2016 | 8 | 0.190 |
Why?
|
| Patient Discharge | 3 | 2016 | 507 | 0.180 |
Why?
|
| Anesthetics, Dissociative | 1 | 2001 | 7 | 0.180 |
Why?
|
| Pilot Projects | 9 | 2016 | 1020 | 0.180 |
Why?
|
| Ketamine | 1 | 2001 | 38 | 0.170 |
Why?
|
| Shock | 3 | 2016 | 32 | 0.170 |
Why?
|
| Risk Factors | 10 | 2020 | 5342 | 0.170 |
Why?
|
| Hydroxychloroquine | 1 | 2020 | 22 | 0.170 |
Why?
|
| Physical Examination | 3 | 2010 | 111 | 0.170 |
Why?
|
| Physician Assistants | 1 | 2000 | 36 | 0.170 |
Why?
|
| Prognosis | 5 | 2025 | 1769 | 0.160 |
Why?
|
| Academic Medical Centers | 7 | 2020 | 313 | 0.160 |
Why?
|
| ROC Curve | 3 | 2025 | 288 | 0.160 |
Why?
|
| Adolescent | 12 | 2025 | 6305 | 0.160 |
Why?
|
| Medical Staff, Hospital | 1 | 2000 | 59 | 0.160 |
Why?
|
| Pain | 2 | 2005 | 407 | 0.160 |
Why?
|
| Treatment Outcome | 7 | 2020 | 5697 | 0.150 |
Why?
|
| Probability | 3 | 2012 | 169 | 0.150 |
Why?
|
| Continuity of Patient Care | 1 | 2001 | 174 | 0.150 |
Why?
|
| Visual Analog Scale | 1 | 2019 | 9 | 0.150 |
Why?
|
| Analgesics | 1 | 2000 | 102 | 0.150 |
Why?
|
| Outpatients | 1 | 2020 | 140 | 0.150 |
Why?
|
| Inpatients | 2 | 2020 | 303 | 0.150 |
Why?
|
| Mental Competency | 1 | 1999 | 62 | 0.150 |
Why?
|
| Patient Education as Topic | 1 | 2002 | 478 | 0.150 |
Why?
|
| Occupational Diseases | 1 | 2021 | 267 | 0.150 |
Why?
|
| Quality Assurance, Health Care | 1 | 2001 | 254 | 0.150 |
Why?
|
| Recovery of Function | 1 | 2020 | 286 | 0.140 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2005 | 698 | 0.140 |
Why?
|
| Public Opinion | 1 | 1998 | 25 | 0.140 |
Why?
|
| Ambulatory Care | 1 | 2020 | 317 | 0.140 |
Why?
|
| Infant, Newborn | 3 | 2023 | 1375 | 0.130 |
Why?
|
| Sheep | 2 | 2008 | 182 | 0.130 |
Why?
|
| Body Mass Index | 2 | 2014 | 874 | 0.130 |
Why?
|
| Fever | 1 | 2017 | 66 | 0.130 |
Why?
|
| Lactic Acid | 3 | 2016 | 75 | 0.130 |
Why?
|
| Headache | 1 | 2017 | 58 | 0.130 |
Why?
|
| Feasibility Studies | 2 | 2011 | 577 | 0.130 |
Why?
|
| Acetates | 2 | 2010 | 34 | 0.130 |
Why?
|
| Craniocerebral Trauma | 1 | 2017 | 55 | 0.130 |
Why?
|
| Shock, Hemorrhagic | 1 | 1996 | 19 | 0.130 |
Why?
|
| Quinolines | 2 | 2010 | 48 | 0.130 |
Why?
|
| Massachusetts | 6 | 2009 | 2096 | 0.120 |
Why?
|
| Risk Assessment | 4 | 2012 | 2049 | 0.120 |
Why?
|
| Analgesics, Opioid | 2 | 2016 | 531 | 0.120 |
Why?
|
| Young Adult | 8 | 2025 | 4781 | 0.120 |
Why?
|
| Patient Admission | 5 | 2009 | 198 | 0.120 |
Why?
|
| Triage | 1 | 2017 | 128 | 0.120 |
Why?
|
| Vasoconstrictor Agents | 1 | 2016 | 70 | 0.120 |
Why?
|
| Retrospective Studies | 8 | 2013 | 6742 | 0.120 |
Why?
|
| Blood Pressure | 3 | 1996 | 517 | 0.120 |
Why?
|
| Confidence Intervals | 3 | 2010 | 239 | 0.110 |
Why?
|
| Infusions, Intravenous | 3 | 2010 | 176 | 0.110 |
Why?
|
| Reminder Systems | 1 | 2016 | 75 | 0.110 |
Why?
|
| Shock, Septic | 1 | 2016 | 85 | 0.110 |
Why?
|
| Case-Control Studies | 3 | 2023 | 1131 | 0.110 |
Why?
|
| Phosphorus Isotopes | 2 | 2011 | 7 | 0.110 |
Why?
|
| Hemorrhage | 1 | 1996 | 275 | 0.110 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2015 | 50 | 0.110 |
Why?
|
| Vaccines, Combined | 2 | 2023 | 9 | 0.100 |
Why?
|
| Virus Diseases | 2 | 2025 | 123 | 0.100 |
Why?
|
| Observation | 2 | 2010 | 30 | 0.100 |
Why?
|
| Cross-Over Studies | 2 | 2012 | 163 | 0.100 |
Why?
|
| Biomarkers | 2 | 2025 | 1431 | 0.100 |
Why?
|
| Lactates | 4 | 2003 | 29 | 0.100 |
Why?
|
| Referral and Consultation | 3 | 2001 | 428 | 0.100 |
Why?
|
| Analysis of Variance | 4 | 2002 | 608 | 0.100 |
Why?
|
| Decision Support Techniques | 1 | 2015 | 192 | 0.100 |
Why?
|
| Exercise Test | 2 | 2005 | 254 | 0.100 |
Why?
|
| Electronic Health Records | 1 | 2016 | 368 | 0.090 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2014 | 248 | 0.090 |
Why?
|
| Infant | 2 | 2017 | 1664 | 0.090 |
Why?
|
| Sensitivity and Specificity | 6 | 2012 | 1164 | 0.090 |
Why?
|
| Single-Blind Method | 3 | 2008 | 144 | 0.090 |
Why?
|
| Decision Making | 2 | 2010 | 416 | 0.090 |
Why?
|
| Half-Life | 1 | 2012 | 79 | 0.090 |
Why?
|
| Evidence-Based Medicine | 2 | 2007 | 462 | 0.090 |
Why?
|
| Respiration, Artificial | 1 | 2014 | 296 | 0.090 |
Why?
|
| Crowding | 2 | 2009 | 34 | 0.090 |
Why?
|
| Radiation Injuries | 1 | 2012 | 66 | 0.090 |
Why?
|
| Area Under Curve | 1 | 2012 | 149 | 0.090 |
Why?
|
| Aminophylline | 2 | 2003 | 4 | 0.090 |
Why?
|
| Spectrophotometry | 1 | 2011 | 34 | 0.090 |
Why?
|
| Metabolic Clearance Rate | 1 | 2011 | 49 | 0.090 |
Why?
|
| Radio Waves | 1 | 2011 | 21 | 0.090 |
Why?
|
| Automation | 1 | 2011 | 54 | 0.090 |
Why?
|
| Resuscitation | 4 | 1999 | 74 | 0.090 |
Why?
|
| Muscular Diseases | 1 | 2011 | 51 | 0.080 |
Why?
|
| Diagnostic Self Evaluation | 1 | 2010 | 24 | 0.080 |
Why?
|
| Muscles | 1 | 2011 | 179 | 0.080 |
Why?
|
| Body Temperature | 2 | 2008 | 45 | 0.080 |
Why?
|
| Geography | 1 | 2009 | 37 | 0.080 |
Why?
|
| Carbon Dioxide | 1 | 2010 | 86 | 0.080 |
Why?
|
| Health Status Indicators | 1 | 2010 | 95 | 0.080 |
Why?
|
| Medical History Taking | 1 | 2010 | 68 | 0.080 |
Why?
|
| Wounds and Injuries | 2 | 2003 | 251 | 0.080 |
Why?
|
| Clinical Competence | 1 | 2014 | 730 | 0.080 |
Why?
|
| Statistics as Topic | 1 | 2010 | 147 | 0.080 |
Why?
|
| Disposable Equipment | 1 | 2009 | 5 | 0.080 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2009 | 75 | 0.080 |
Why?
|
| Anti-Asthmatic Agents | 1 | 2010 | 41 | 0.080 |
Why?
|
| Kinetics | 1 | 2011 | 766 | 0.080 |
Why?
|
| Forehead | 1 | 2009 | 16 | 0.080 |
Why?
|
| Antifibrinolytic Agents | 1 | 2009 | 16 | 0.070 |
Why?
|
| Blood Circulation | 2 | 2003 | 8 | 0.070 |
Why?
|
| Forecasting | 1 | 2010 | 233 | 0.070 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2011 | 215 | 0.070 |
Why?
|
| Equipment Design | 2 | 2004 | 362 | 0.070 |
Why?
|
| Medication Reconciliation | 1 | 2008 | 14 | 0.070 |
Why?
|
| RNA, Messenger | 2 | 2025 | 1551 | 0.070 |
Why?
|
| Hospitals, Urban | 1 | 2008 | 43 | 0.070 |
Why?
|
| Opioid-Related Disorders | 1 | 2016 | 513 | 0.070 |
Why?
|
| Diabetic Ketoacidosis | 1 | 2008 | 12 | 0.070 |
Why?
|
| Laboratories, Hospital | 1 | 2008 | 10 | 0.070 |
Why?
|
| Hypertension, Pulmonary | 1 | 2009 | 97 | 0.070 |
Why?
|
| Length of Stay | 2 | 2009 | 819 | 0.070 |
Why?
|
| Stroke Volume | 1 | 2010 | 330 | 0.070 |
Why?
|
| Quality of Health Care | 1 | 2012 | 526 | 0.070 |
Why?
|
| Ventricular Function, Left | 1 | 2010 | 271 | 0.070 |
Why?
|
| Self Report | 1 | 2010 | 388 | 0.070 |
Why?
|
| Resource Allocation | 2 | 2008 | 19 | 0.070 |
Why?
|
| Medication Errors | 1 | 2008 | 109 | 0.070 |
Why?
|
| Coronary Artery Bypass | 1 | 2010 | 297 | 0.070 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2008 | 44 | 0.070 |
Why?
|
| Ambulances | 2 | 2009 | 24 | 0.070 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2011 | 677 | 0.070 |
Why?
|
| Odds Ratio | 4 | 2012 | 759 | 0.070 |
Why?
|
| Diagnosis, Differential | 4 | 2015 | 984 | 0.060 |
Why?
|
| Internship and Residency | 1 | 2014 | 808 | 0.060 |
Why?
|
| Health Services Accessibility | 2 | 2009 | 575 | 0.060 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 2006 | 25 | 0.060 |
Why?
|
| Point-of-Care Systems | 1 | 2008 | 132 | 0.060 |
Why?
|
| Oxygen Inhalation Therapy | 2 | 2005 | 60 | 0.060 |
Why?
|
| Random Allocation | 1 | 2006 | 201 | 0.060 |
Why?
|
| Tachycardia | 2 | 2009 | 29 | 0.060 |
Why?
|
| Disease Progression | 1 | 2010 | 1176 | 0.060 |
Why?
|
| Survival Analysis | 1 | 2007 | 587 | 0.060 |
Why?
|
| Lacerations | 1 | 2005 | 15 | 0.060 |
Why?
|
| Blood Glucose | 1 | 2008 | 487 | 0.060 |
Why?
|
| Animals | 4 | 2008 | 20962 | 0.060 |
Why?
|
| Testis | 1 | 2006 | 152 | 0.060 |
Why?
|
| Dyspareunia | 1 | 2005 | 9 | 0.060 |
Why?
|
| Algorithms | 3 | 2025 | 1029 | 0.060 |
Why?
|
| Cohort Studies | 2 | 2025 | 2605 | 0.060 |
Why?
|
| Medical Records | 2 | 2008 | 138 | 0.060 |
Why?
|
| Pulmonary Gas Exchange | 1 | 2005 | 43 | 0.060 |
Why?
|
| Health Services Needs and Demand | 2 | 2005 | 214 | 0.060 |
Why?
|
| Pandemics | 2 | 2020 | 676 | 0.060 |
Why?
|
| Spirometry | 1 | 2005 | 112 | 0.060 |
Why?
|
| Positive-Pressure Respiration | 1 | 2005 | 51 | 0.060 |
Why?
|
| Health Services Misuse | 1 | 2005 | 18 | 0.060 |
Why?
|
| Diagnosis-Related Groups | 2 | 2005 | 87 | 0.060 |
Why?
|
| Radiography, Thoracic | 1 | 2005 | 117 | 0.060 |
Why?
|
| Ischemia | 1 | 2006 | 196 | 0.050 |
Why?
|
| Bronchodilator Agents | 1 | 2005 | 119 | 0.050 |
Why?
|
| Confined Spaces | 1 | 2004 | 1 | 0.050 |
Why?
|
| Morphine | 1 | 2004 | 59 | 0.050 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2005 | 181 | 0.050 |
Why?
|
| Exercise | 1 | 2011 | 954 | 0.050 |
Why?
|
| Appendicitis | 1 | 2004 | 83 | 0.050 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2003 | 55 | 0.050 |
Why?
|
| Creatine Kinase, MB Form | 1 | 2003 | 9 | 0.050 |
Why?
|
| Epidemiologic Studies | 1 | 2003 | 34 | 0.050 |
Why?
|
| Carboxyhemoglobin | 1 | 2003 | 12 | 0.050 |
Why?
|
| Leukotriene Antagonists | 1 | 2002 | 8 | 0.050 |
Why?
|
| Cardiotonic Agents | 1 | 2003 | 54 | 0.050 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2007 | 788 | 0.050 |
Why?
|
| Emergencies | 1 | 2003 | 121 | 0.050 |
Why?
|
| Nursing Evaluation Research | 1 | 2002 | 40 | 0.050 |
Why?
|
| Postoperative Complications | 1 | 2010 | 1301 | 0.050 |
Why?
|
| Transportation of Patients | 1 | 2002 | 50 | 0.050 |
Why?
|
| Social Work Department, Hospital | 1 | 2001 | 1 | 0.050 |
Why?
|
| Adolescent, Hospitalized | 1 | 2001 | 2 | 0.050 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2011 | 2218 | 0.050 |
Why?
|
| Angiography | 2 | 2015 | 151 | 0.050 |
Why?
|
| Alcoholic Intoxication | 1 | 2001 | 27 | 0.040 |
Why?
|
| Cross-Sectional Studies | 2 | 2017 | 2621 | 0.040 |
Why?
|
| Medical Errors | 1 | 2003 | 198 | 0.040 |
Why?
|
| Dogs | 1 | 2003 | 332 | 0.040 |
Why?
|
| Immunization, Secondary | 1 | 2021 | 50 | 0.040 |
Why?
|
| Immunization Schedule | 1 | 2021 | 18 | 0.040 |
Why?
|
| Models, Theoretical | 1 | 2003 | 272 | 0.040 |
Why?
|
| X-Rays | 1 | 2001 | 46 | 0.040 |
Why?
|
| Vaccination | 1 | 2023 | 371 | 0.040 |
Why?
|
| Urban Health | 1 | 2000 | 41 | 0.040 |
Why?
|
| Reference Values | 2 | 2003 | 333 | 0.040 |
Why?
|
| Radiology Department, Hospital | 1 | 2001 | 25 | 0.040 |
Why?
|
| Recurrence | 1 | 2002 | 652 | 0.040 |
Why?
|
| Ultrasonography | 1 | 2003 | 486 | 0.040 |
Why?
|
| Age Factors | 2 | 2012 | 1570 | 0.040 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2005 | 489 | 0.040 |
Why?
|
| Treatment Failure | 1 | 2020 | 201 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 1 | 2021 | 518 | 0.040 |
Why?
|
| Etomidate | 1 | 2000 | 8 | 0.040 |
Why?
|
| Pacemaker, Artificial | 1 | 2000 | 49 | 0.040 |
Why?
|
| Hypnotics and Sedatives | 1 | 2000 | 65 | 0.040 |
Why?
|
| Wechsler Scales | 1 | 1999 | 16 | 0.040 |
Why?
|
| Adrenal Insufficiency | 1 | 1999 | 10 | 0.040 |
Why?
|
| Anti-Bacterial Agents | 1 | 2005 | 800 | 0.040 |
Why?
|
| Disease Models, Animal | 1 | 2006 | 2238 | 0.040 |
Why?
|
| Multivariate Analysis | 2 | 2012 | 930 | 0.040 |
Why?
|
| Hypotension | 1 | 1999 | 50 | 0.040 |
Why?
|
| Drug Utilization | 1 | 2000 | 208 | 0.040 |
Why?
|
| Regression Analysis | 2 | 2014 | 498 | 0.040 |
Why?
|
| Prevalence | 1 | 2003 | 1407 | 0.040 |
Why?
|
| Survival Rate | 3 | 2016 | 859 | 0.040 |
Why?
|
| Inflammation | 1 | 2005 | 1162 | 0.040 |
Why?
|
| Patient Readmission | 1 | 2002 | 432 | 0.040 |
Why?
|
| Patient Care Team | 1 | 2001 | 340 | 0.030 |
Why?
|
| Fibrinolytic Agents | 1 | 1999 | 173 | 0.030 |
Why?
|
| Clothing | 1 | 1998 | 6 | 0.030 |
Why?
|
| Intubation, Intratracheal | 1 | 2000 | 203 | 0.030 |
Why?
|
| Socioeconomic Factors | 1 | 2020 | 788 | 0.030 |
Why?
|
| General Surgery | 1 | 2000 | 214 | 0.030 |
Why?
|
| Urban Population | 3 | 2009 | 198 | 0.030 |
Why?
|
| Sulfides | 2 | 2010 | 24 | 0.030 |
Why?
|
| Emergency Nursing | 2 | 2008 | 20 | 0.030 |
Why?
|
| Pulse | 1 | 1996 | 16 | 0.030 |
Why?
|
| Blood Donors | 1 | 1996 | 22 | 0.030 |
Why?
|
| Hypotension, Orthostatic | 1 | 1996 | 27 | 0.030 |
Why?
|
| Cyclopropanes | 2 | 2010 | 54 | 0.030 |
Why?
|
| Educational Status | 1 | 1998 | 278 | 0.030 |
Why?
|
| Data Collection | 1 | 1998 | 384 | 0.030 |
Why?
|
| Forced Expiratory Volume | 2 | 2010 | 209 | 0.030 |
Why?
|
| Health Care Surveys | 2 | 2008 | 289 | 0.030 |
Why?
|
| Insurance, Health | 2 | 2008 | 151 | 0.030 |
Why?
|
| Cognition | 1 | 1999 | 491 | 0.030 |
Why?
|
| Critical Illness | 2 | 1999 | 327 | 0.030 |
Why?
|
| Attitude of Health Personnel | 1 | 2000 | 620 | 0.030 |
Why?
|
| Patient Satisfaction | 1 | 1998 | 439 | 0.030 |
Why?
|
| Canada | 1 | 2014 | 151 | 0.030 |
Why?
|
| Physician-Patient Relations | 1 | 1998 | 424 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2016 | 735 | 0.030 |
Why?
|
| Ventilators, Mechanical | 1 | 1994 | 30 | 0.030 |
Why?
|
| Coronary Circulation | 1 | 1994 | 53 | 0.030 |
Why?
|
| Self Efficacy | 1 | 2014 | 203 | 0.030 |
Why?
|
| Child | 2 | 2017 | 4583 | 0.030 |
Why?
|
| Pituitary-Adrenal System | 1 | 1993 | 60 | 0.030 |
Why?
|
| Patient Selection | 1 | 2016 | 487 | 0.020 |
Why?
|
| Educational Measurement | 1 | 2014 | 219 | 0.020 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 1993 | 88 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2017 | 726 | 0.020 |
Why?
|
| Overweight | 1 | 2014 | 252 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2016 | 1272 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1993 | 625 | 0.020 |
Why?
|
| Echocardiography | 1 | 2015 | 509 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2017 | 2019 | 0.020 |
Why?
|
| Incidence | 2 | 2009 | 1385 | 0.020 |
Why?
|
| Exhalation | 1 | 2010 | 15 | 0.020 |
Why?
|
| Radiography | 1 | 2012 | 553 | 0.020 |
Why?
|
| Capnography | 1 | 2010 | 7 | 0.020 |
Why?
|
| Thrombophilia | 1 | 2010 | 14 | 0.020 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2011 | 296 | 0.020 |
Why?
|
| Bundle-Branch Block | 1 | 2009 | 15 | 0.020 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2009 | 45 | 0.020 |
Why?
|
| Travel | 1 | 2009 | 44 | 0.020 |
Why?
|
| Likelihood Functions | 1 | 2009 | 69 | 0.020 |
Why?
|
| Rats | 1 | 1993 | 2005 | 0.020 |
Why?
|
| Respiratory Function Tests | 1 | 2010 | 190 | 0.020 |
Why?
|
| Chest Pain | 1 | 2010 | 84 | 0.020 |
Why?
|
| Hospital Bed Capacity | 1 | 2008 | 27 | 0.020 |
Why?
|
| Blood Specimen Collection | 1 | 2008 | 20 | 0.020 |
Why?
|
| Hospitals, University | 1 | 2008 | 56 | 0.020 |
Why?
|
| Appendectomy | 1 | 2008 | 56 | 0.020 |
Why?
|
| False Negative Reactions | 1 | 2008 | 41 | 0.020 |
Why?
|
| Quality Improvement | 1 | 2012 | 455 | 0.020 |
Why?
|
| Hospital Costs | 1 | 2008 | 126 | 0.020 |
Why?
|
| Cost of Illness | 1 | 2008 | 169 | 0.020 |
Why?
|
| Adrenocorticotropic Hormone | 2 | 1999 | 24 | 0.020 |
Why?
|
| Sex Factors | 1 | 2010 | 980 | 0.020 |
Why?
|
| Obesity | 1 | 2014 | 1248 | 0.020 |
Why?
|
| Hemodynamics | 2 | 2000 | 249 | 0.020 |
Why?
|
| Body Composition | 1 | 2006 | 153 | 0.010 |
Why?
|
| Clinical Protocols | 1 | 2006 | 135 | 0.010 |
Why?
|
| Anemia, Sickle Cell | 1 | 2005 | 64 | 0.010 |
Why?
|
| Sex Distribution | 1 | 2005 | 251 | 0.010 |
Why?
|
| Age Distribution | 1 | 2005 | 258 | 0.010 |
Why?
|
| Employment | 1 | 2005 | 128 | 0.010 |
Why?
|
| Poisson Distribution | 1 | 2003 | 53 | 0.010 |
Why?
|
| Pain Threshold | 1 | 2003 | 25 | 0.010 |
Why?
|
| Adipose Tissue | 1 | 2006 | 297 | 0.010 |
Why?
|
| Advanced Cardiac Life Support | 1 | 2003 | 16 | 0.010 |
Why?
|
| Albuterol | 1 | 2002 | 24 | 0.010 |
Why?
|
| Adrenergic beta-Agonists | 1 | 2002 | 34 | 0.010 |
Why?
|
| Pain Management | 1 | 2005 | 169 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 2002 | 156 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2003 | 412 | 0.010 |
Why?
|
| Brain | 1 | 1991 | 1581 | 0.010 |
Why?
|
| Social Support | 1 | 2005 | 376 | 0.010 |
Why?
|
| Heart Rate | 2 | 1994 | 328 | 0.010 |
Why?
|
| Trauma Severity Indices | 1 | 2001 | 34 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2002 | 467 | 0.010 |
Why?
|
| New England | 1 | 2001 | 269 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2002 | 869 | 0.010 |
Why?
|
| Accidents, Traffic | 1 | 2001 | 147 | 0.010 |
Why?
|
| Equipment Failure | 1 | 2000 | 68 | 0.010 |
Why?
|
| Purinergic P1 Receptor Antagonists | 1 | 1999 | 4 | 0.010 |
Why?
|
| Registries | 1 | 2001 | 885 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 1998 | 215 | 0.010 |
Why?
|
| Mass Screening | 1 | 2001 | 693 | 0.010 |
Why?
|
| Abdomen | 1 | 1994 | 94 | 0.010 |
Why?
|
| Respiration | 1 | 1994 | 92 | 0.010 |
Why?
|
| Cosyntropin | 1 | 1993 | 1 | 0.010 |
Why?
|
| Blood Circulation Time | 1 | 1992 | 1 | 0.010 |
Why?
|
| Vascular Resistance | 1 | 1992 | 47 | 0.010 |
Why?
|
| Epinephrine | 1 | 1992 | 47 | 0.010 |
Why?
|
| Veins | 1 | 1992 | 64 | 0.010 |
Why?
|
| Catheterization, Central Venous | 1 | 1992 | 83 | 0.010 |
Why?
|
| Monitoring, Physiologic | 1 | 1992 | 163 | 0.010 |
Why?
|
| Jugular Veins | 1 | 1991 | 29 | 0.010 |
Why?
|
| Arteries | 1 | 1991 | 80 | 0.010 |
Why?
|
| Aorta | 1 | 1991 | 110 | 0.010 |
Why?
|
| Brain Ischemia | 1 | 1993 | 421 | 0.000 |
Why?
|